Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

A-to-I RNA Editing Contributes to Proteomic Diversity in Cancer.

Cancer cell | 2018

Adenosine (A) to inosine (I) RNA editing introduces many nucleotide changes in cancer transcriptomes. However, due to the complexity of post-transcriptional regulation, the contribution of RNA editing to proteomic diversity in human cancers remains unclear. Here, we performed an integrated analysis of TCGA genomic data and CPTAC proteomic data. Despite limited site diversity, we demonstrate that A-to-I RNA editing contributes to proteomic diversity in breast cancer through changes in amino acid sequences. We validate the presence of editing events at both RNA and protein levels. The edited COPA protein increases proliferation, migration, and invasion of cancer cells in vitro. Our study suggests an important contribution of A-to-I RNA editing to protein diversity in cancer and highlights its translational potential.

Pubmed ID: 29706454 RIS Download

Associated grants

  • Agency: NCI NIH HHS, United States
    Id: P30 CA016672
  • Agency: NCI NIH HHS, United States
    Id: P50 CA098258
  • Agency: NCI NIH HHS, United States
    Id: U01 CA168394
  • Agency: NCI NIH HHS, United States
    Id: U01 CA217842
  • Agency: NCI NIH HHS, United States
    Id: R01 CA175486
  • Agency: NIH HHS, United States
    Id: S10 OD012304
  • Agency: NCI NIH HHS, United States
    Id: U24 CA143883
  • Agency: NCI NIH HHS, United States
    Id: U24 CA209851
  • Agency: NCI NIH HHS, United States
    Id: R50 CA221675

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Cancer Genomics Hub (tool)

RRID:SCR_002657

THIS RESOURCE IS NO LONGER IN SERVICE. Documented on March 17, 2022. A secure repository for storing, cataloging, and accessing cancer genome sequences, alignments, and mutation information from the Cancer Genome Atlas (TCGA) consortium and related projects. CGHub gives scientific researchers the statistical power of large cancer genome datasets to attack the molecular complexity of cancer.

View all literature mentions

ProteoWizard (tool)

RRID:SCR_012056

Software that enables rapid tool creation by providing a robust, pluggable development framework that simplifies and unifies data file access, and performs standard proteomics and LCMS dataset computations.

View all literature mentions

ANNOVAR (tool)

RRID:SCR_012821

An efficient software tool to utilize update-to-date information to functionally annotate genetic variants detected from diverse genomes (including human genome hg18, hg19, as well as mouse, worm, fly, yeast and many others). Given a list of variants with chromosome, start position, end position, reference nucleotide and observed nucleotides, ANNOVAR can perform: 1. gene-based annotation. 2. region-based annotation. 3. filter-based annotation. 4. other functionalities. (entry from Genetic Analysis Software)

View all literature mentions

PolyPhen: Polymorphism Phenotyping (tool)

RRID:SCR_013189

Software tool which predicts possible impact of amino acid substitution on structure and function of human protein using straightforward physical and comparative considerations. PolyPhen-2 is new development of PolyPhen tool for annotating coding nonsynonymous SNPs.

View all literature mentions

I-TASSER (tool)

RRID:SCR_014627

Web server as integrated platform for automated protein structure and function prediction. Used for protein 3D structure prediction. Resource for automated protein structure prediction and structure-based function annotation.

View all literature mentions

GAPDH Antibody (FL-335) (antibody)

RRID:AB_10167668

This polyclonal targets GAPDH

View all literature mentions

ERK 2 (C-14) (antibody)

RRID:AB_2141292

This monoclonal targets ERK 2

View all literature mentions

Anti-COPA polyclonal antibody (antibody)

RRID:AB_10603787

This polyclonal targets COPA

View all literature mentions

COG3 antibody (antibody)

RRID:AB_2081402

This polyclonal targets COG3

View all literature mentions

alpha-Tubulin Antibody (antibody)

RRID:AB_2210548

This polyclonal targets alpha-Tubulin

View all literature mentions